BioCentury
ARTICLE | Finance

Rig-ging an exit

Rigontec takeout gives Wellington quick exit, momentum into new fund

September 8, 2017 6:33 PM UTC

Wellington Partners’ quick exit from Rigontec GmbH will not only be one of the firm’s best returns from its current fund, but could bolster its fund-raising efforts for a third life sciences fund.

On Sept. 6, Merck & Co. Inc. (NYSE:MRK) announced it will acquire Rigontec for €115 million ($136.8 million) up front and up to €349 million ($415.2 million) in milestones. ...

BCIQ Company Profiles

Rigontec GmbH